vertigo from semaglutide GLP-1 meds like (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have been game-changers for diabetes and weight loss — but a new study found they may also slightly increase the risk of developing vestibular Ozempic and Wegovy in Black

Data from multiple large-scale randomized controlled trials and meta-analyses have consistently shown no increase in pancreatic cancer incidence among people treated with semaglutide compared to placebo or other diabetes medications

Subcutaneous (GQ) injections

Food and Drug Administration (FDA) to improve glycemic control in patients with type 2 diabetes mellitus (T2DM), along with exercise and a balanced diet

The honest answer: Retatrutide looks more powerful on headline weight-loss potential, but there is no true head-to-head trial against CagriSema yet

For many people, the choice between an unaffordable pharmaceutical product and a cheap research chemical is not really a choice at all